URI LEVINE

Infosys key Products/Revenue Segments include Software Development Charges and Software Products for the year ending 31-Mar-2022.

Promoters held 15.11 per cent stake in the company as of 31-Dec-2022, while FIIs owned 36.29 per cent, DIIs 32.38 per cent.

Key beneficiary of improved digital demand, industry leading revenue growth and healthy capital allocation prompts the brokerage to be posi...

Infosys, incorporated in the year 1981, is a Large Cap company (having a market cap of Rs 619038.52 Crore) operating in IT Software sector.

Infosys, incorporated in the year 1981, is a Large Cap company (having a market cap of Rs 649115.56 Crore) operating in IT Software sector.

The brokerage believes Indian IT’s higher presence in India bodes well amid shift towards global delivery centres due to talent shortage in...

Infosys, incorporated in the year 1981, is a Large Cap company (having a market cap of Rs 662971.50 Crore) operating in IT Software sector.

Infosys, incorporated in the year 1981, is a Large Cap company (having a market cap of Rs 621685.48 Crore) operating in IT Software sector.

Margin levers include large scope for utilisation increase, following strong fresher hiring.

The brokerage values the stock at 26x FY24E EPS and reiterates its Buy rating.

Singhal will be overseeing the overall product strategy and engineering execution to deliver customer experience across all the markets whe...

The brokerage expects Infosys to deliver margin on the lower side of its guidance band, with strong growth and reduced dependence on sub-co...

Infosys, incorporated in the year 1981, is a Large Cap company (having a market cap of Rs 613417.10 Crore) operating in IT Software sector.

Zoomcar operates a marketplace for private vehicles, with owners making their cars available on the platform and users able to rent them by...

“Nirmal’s diverse skill sets and seasoned leadership will play an instrumental role in continuing to scale the India business. I am confide...

Members of Infosys’ ESG committee include Chitra Nayak and Uri Levine, independent directors on the company’s board. Biocon’s Kiran Mazumda...